Multifaceted roles of cysteinyl leukotrienes in eliciting eosinophil granule protein secretion

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Baptista Dos Reis, Renata ^a   Muniz, Valdirene S ^a   Neves, Josiane S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL GRANULE PROTEIN; EOTAXIN; INTERLEUKIN 12; INTERLEUKIN 16; INTERLEUKIN 4; PEPTIDOLEUKOTRIENE; RANTES; CYSTEINYL LEUKOTRIENE RECEPTOR 2; LEUKOTRIENE; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE RECEPTOR;

AUTOCRINE EFFECT; CELL MEMBRANE; CELL SURFACE; EOSINOPHIL; HUMAN; IMMUNOBIOLOGY; INFLAMMATION; LIGAND BINDING; NONHUMAN; PARACRINE SIGNALING; PROTEIN DOMAIN; PROTEIN SECRETION; REVIEW; ANIMAL; GENE EXPRESSION REGULATION; IMMUNOLOGY; SECRETORY VESICLE;

VERMES;

ANIMALS; AUTOCRINE COMMUNICATION; CELL MEMBRANE; EOSINOPHILS; GENE EXPRESSION REGULATION; HUMANS; LEUKOTRIENES; PARACRINE COMMUNICATION; RECEPTORS, LEUKOTRIENE; SECRETORY VESICLES;

EID: 84926512802     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/848762     Document Type: Review

References (50)

1. M. Peters-Golden and W. R. Henderson Jr., "Leukotrienes," The New England Journal of Medicine, Vol. 357, no. 18, pp. 1841-1854, 2007.
2. P. T. Bozza, I. Bakker-Abreu, R. A. Navarro-Xavier, and C. Bandeira-Melo, "Lipid body function in eicosanoid synthesis: an update," Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 85, no. 5, pp. 205-213, 2011.
3. G. E. Rovati and V. Capra, "Cysteinyl-leukotriene receptors and cellular signals," The Scientific World Journal, Vol. 7, pp. 1375-1392, 2007.
4. C. E. Heise, B. F. O'Dowd, D. J. Figueroa et al., "Characterization of the human cysteinyl leukotriene 2 receptor," The Journal of Biological Chemistry, Vol. 275, no. 39, pp. 30531-30536, 2000.
5. K. R. Lynch, G. P. O'Neill, Q. Liu et al., "Characterization of the human cysteinyl leukotriene CysLT1 receptor," Nature, Vol. 399, no. 6738, pp. 789-793, 1999.
6. R. A. Panettieri Jr., E. M. L. Tan, V. Ciocca, M. A. Luttmann, T. B. Leonard, and D. W. P. Hey, "Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists," The American Journal of Respiratory Cell and Molecular Biology, Vol. 19, no. 3, pp. 453-461, 1998.
7. E. A. Mellor, K. F. Austen, and J. A. Boyce, "Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists," The Journal of Experimental Medicine, Vol. 195, no. 5, pp. 583-592, 2002.
8. S. Ravasi, V. Capra, M. Mezzetti, S. Nicosia, and G. E. Rovati, "A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C4 binding site not coupled to contraction in human lung parenchyma," Molecular Pharmacology, Vol. 57, no. 6, pp. 1182-1189, 2000.
9. 4: perspective on the forgotten mediator," Journal of Allergy and Clinical Immunology, Vol. 124, no. 3, pp. 417-421, 2009.
10. K. F. Austen, A. Maekawa, Y. Kanaoka, and J. A. Boyce, "The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications," Journal of Allergy and Clinical Immunology, Vol. 124, no. 3, pp. 406-414, 2009.
11. G. M. Gauvreau, K. N. Parameswaran, R. M. Watson, and P. M. O'Byrne, "Inhaled leukotriene E4, but not leukotriene D4, increased airway inflammatory cells in subjects with atopic asthma," The American Journal of Respiratory and Critical Care Medicine, Vol. 164, no. 8, part 1, pp. 1495-1500, 2001.
12. Y. Nonaka, T. Hiramoto, and N. Fujita, "Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods," Biochemical and Biophysical Research Communications, Vol. 337, no. 1, pp. 281-288, 2005.
13. S. Paruchuri, H. Tashimo, C. Feng et al., "Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor," Journal of Experimental Medicine, Vol. 206, no. 11, pp. 2543-2555, 2009.
14. H. R. Foster, E. Fuerst, T. H. Lee, D. J. Cousins, and G. Woszczek, "Characterisation of P2Y(12) receptor responsiveness to cysteinyl leukotrienes," PLoS ONE, Vol. 8, no. 3, Article ID e58305, 2013.
15. V. Capra, M. D. Thompson, A. Sala, D. E. Cole, G. Folco, and G. E. Rovati, "Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends," Medicinal Research Reviews, Vol. 27, no. 4, pp. 469-527, 2007.
16. G. Milligan, "G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function," British Journal of Pharmacology, Vol. 158, no. 1, pp. 5-14, 2009.
17. C. Bandeira-Melo and P. F. Weller, "Eosinophils and cysteinyl leukotrienes," Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 69, no. 2-3, pp. 135-143, 2003.
18. Y. Kanaoka and J. A. Boyce, "Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses," The Journal of Immunology, Vol. 173, no. 3, pp. 1503-1510, 2004.
19. C. Blanchard and M. E. Rothenberg, "Biology of the eosinophil," Advances in Immunology, Vol. 101, pp. 81-121, 2009.
20. L. A. Spencer, C. T. Szela, S. A. C. Perez et al., "Human eosinophils constitutively express multiple th1, th2, and immunoregulatory cytokines that are secreted rapidly and differentially," Journal of Leukocyte Biology, Vol. 85, no. 1, pp. 117-123, 2009.
21. R. Moqbel and J. J. Coughlin, "Differential secretion of cytokines," Science's STKE, Vol. 2006, no. 338, article pe26, 2006.
22. L. A. Spencer, R. C. N. Melo, S. A. C. Perez, S. P. Bafford, A. M. Dvorak, and P. F. Weller, "Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion," Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, no. 9, pp. 3333-3338, 2006.
23. R. C. Melo, L. A. Spencer, A. M. Dvorak, and P. F. Weller, "Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins," Journal of Leukocyte Biology, Vol. 83, no. 2, pp. 229-236, 2008.
24. R. C. Melo, L. A. Spencer, S. A. Perez, I. Ghiran, A. M. Dvorak, and P. F. Weller, "Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments," Traffic, Vol. 6, no. 11, pp. 1047-1057, 2005.
25. R. C. N. Melo, L. A. Spencer, S. A. C. Perez et al., "Vesiclemediated secretion of human eosinophil granule-derived major basic protein," Laboratory Investigation, Vol. 89, no. 7, pp. 769-781, 2009.
26. V. S. Muniz, P. F. Weller, and J. S. Neves, "Eosinophil crystalloid granules: structure, function, and beyond," Journal of Leukocyte Biology, Vol. 92, no. 2, pp. 281-288, 2012.
27. R. C. N. Melo and P. F. Weller, "Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses," Histology and Histopathology, Vol. 25, no. 10, pp. 1341-1354, 2010.
28. M. Karawajczyk, L. Seveus, R. Garcia et al., "Piecemeal degranulation of peripheral blood eosinophils: a study of allergic subjects during and out of the pollen season," American Journal of Respiratory Cell and Molecular Biology, Vol. 23, no. 4, pp. 521-529, 2000.
29. A. M. Dvorak and S. Kissell, "Granule changes of human skin mast cells characteristic of piecemeal degranulation and associated with recovery during wound healing in situ," Journal of Leukocyte Biology, Vol. 49, no. 2, pp. 197-210, 1991.
30. A. M. Dvorak, R. S. McLeod, A. Onderdonk et al., "Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo," International Archives of Allergy and Immunology, Vol. 99, no. 1, pp. 74-83, 1992.
31. J. S. Erjefält, L. Greiff, M. Andersson, E. Ädelroth, and C. G. A. Persson, "Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease," Thorax, Vol. 56, no. 5, pp. 341-344, 2001.
32. C. Bandeira-Melo, L. J. Woods, M. Phoofolo, and P. F. Weller, "Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion," Journal of Experimental Medicine, Vol. 196, no. 6, pp. 841-850, 2002.
33. J. S. Neves, S. A. C. Perez, L. A. Spencer et al., "Eosinophil granules function extracellularly as receptor-mediated secretory organelles," Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, no. 47, pp. 18478-18483, 2008.
34. J. S. Neves, A. L. Radke, and P. F. Weller, "Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules," Journal of Allergy and Clinical Immunology, Vol. 125, no. 2, pp. 477-482, 2010.
35. T. Urasaki, J. Takasaki, T. Nagasawa, and H. Ninomiya, "Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway," Journal of Leukocyte Biology, Vol. 69, no. 1, pp. 105-112, 2001.
36. N. Tedla, C. Bandeira-Melo, P. Tassinari et al., "Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7," Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, no. 3, pp. 1174-1179, 2003.
37. C. Bandeira-Melo, P. T. Bozza, and P. F. Weller, "The cellular biology of eosinophil eicosanoid formation and function," Journal of Allergy and Clinical Immunology, Vol. 109, no. 3, pp. 393-400, 2002.
38. C. Bandeira-Melo, J. C. Hall, J. F. Penrose, and P. F. Weller, "Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils," Journal of Allergy and Clinical Immunology, Vol. 109, no. 6, pp. 975-979, 2002.
39. J. Murray, C. Ward, J. T. O'Flaherty et al., "Role of leukotrienes in the regulation of human granulocyte behaviour: dissociation between agonist-induced activation and retardation of apoptosis," The British Journal of Pharmacology, Vol. 139, no. 2, pp. 388-398, 2003.
40. K. Becler, L. Håkansson, and S. Rak, "Treatment of asthmatic patients with a cysteinyl leukotriene receptor-1 antagonist montelukast (Singulair), decreases the eosinophil survivalenhancing activity produced by peripheral blood mononuclear leukocytes in vitro," Allergy, Vol. 57, no. 11, pp. 1021-1028, 2002.
41. E. Lee, T. Robertson, J. Smith, and S. Kilfeather, "Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals," American Journal of Respiratory and Critical Care Medicine, Vol. 161, no. 6, pp. 1881-1886, 2000.
42. C. Bandeira-Melo and P. F. Weller, "Mechanisms of eosinophil cytokine release," Memorias do Instituto Oswaldo Cruz, Vol. 100, supplement 1, pp. 73-81, 2005.
43. M. Peters-Golden and T. G. Brock, "Intracellular compartmentalization of leukotriene biosynthesis," The American Journal of Respiratory and Critical Care Medicine, Vol. 161, no. 2, part 2, pp. S36-S40, 2000.
44. Y. Jiang, Y. Kanaoka, C. Feng, K. Nocka, S. Rao, and J. A. Boyce, "Cutting edge: interleukin 4-dependent mast cell proliferation requires autocrine/intracrine cysteinyl leukotrieneinduced signaling," Journal of Immunology, Vol. 177, no. 5, pp. 2755-2759, 2006.
45. 4: role in neointimal hyperplasia," Circulation Research, Vol. 112, no. 7, pp. 1013-1025, 2013.
46. 1 receptors on vascular smooth muscle cells transduces nuclear calcium signaling and alterations of gene expression," Journal of Molecular Medicine, Vol. 90, no. 10, pp. 1223-1231, 2012.
47. C. K. Nielsen, J. I. A. Campbell, J. F. Öhd et al., "A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells," Cancer Research, Vol. 65, no. 3, pp. 732-742, 2005.
48. Y. Jiang, L. A. Borrelli, Y. Kanaoka, B. J. Bacskai, and J. A. Boyce, "CysLT2 receptors interact with CysLT1 receptors and downmodulate cysteinyl leukotriene-dependent mitogenic responses of mast cells," Blood, Vol. 110, no. 9, pp. 3263-3270, 2007.
49. J. S. Neves and P. F. Weller, "Functional extracellular eosinophil granules: novel implications in eosinophil immunobiology," Current Opinion in Immunology, Vol. 21, no. 6, pp. 694-699, 2009.
50. J. S. Neves, S. A. C. Perez, L. A. Spencer, R. C. N. Melo, and P. F. Weller, "Subcellular fractionation of human eosinophils: isolation of functional specific granules on isoosmotic density gradients," Journal of Immunological Methods, Vol. 344, no. 1, pp. 64-72, 2009.